What You Ought to Know:
– Panther Life Sciences, a life sciences firm specializing in skin-based remedies utilizing microarray patches (MAPs), has introduced the appointment of Dr. Matthew Hepburn as Govt Vice President of Analysis and Improvement.
– Dr. Hepburn shall be instrumental in driving Panther’s strategic imaginative and prescient to commercialize its patented MAP know-how, with a deal with delivering the primary industrial product to market inside the subsequent two years.
– In his new position, Dr. Hepburn will spearhead the development of Panther’s intensive pipeline of MAP-based remedies throughout numerous therapeutic areas. This initiative goals to capitalize on the multi-billion-dollar market potential for shelf-stable, direct-to-consumer remedies for immune-mediated illnesses and different important well being circumstances.
Dr. Hepburn Bio/Background
Dr. Hepburn brings a wealth of experience in infectious illnesses and a confirmed observe file in speedy product growth. Notably, he served because the vaccine growth lead for Operation Warp Pace through the first Trump Administration, the place he performed a pivotal position in delivering the primary COVID-19 vaccine pictures in file time. His distinguished profession additionally consists of strategic pandemic preparedness and biodefense roles on the White Home, reflecting his deep understanding of vital healthcare challenges.
A doctor and U.S. Military veteran with 23 years of service, Dr. Hepburn’s distinctive mix of scientific expertise and speedy growth experience shall be invaluable as Panther scales its MAP platform to handle circumstances reminiscent of most cancers, allergic reactions, and infectious illnesses on a worldwide scale.
“By making our progressive MAP platform widely-accessible, Panther is poised to revolutionize the best way remedies are delivered, enhancing affected person outcomes and considerably decreasing healthcare price all through,” stated Dr. Hepburn. “I’m impressed by the potential of Panther’s MAP know-how and with our companions, I’m totally dedicated to bringing established and novel remedies to market quicker and extra effectively.”
